EUVIMEDEUVIMED entdecken
Crossref

Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy

Peixia Li, Yayin Du, Jingru Qiu, Qiaoyun Jiang, Weijia Chen, Xinke Zhang iD, Guiling Li, Donghai Li iD, Gang Shan iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Peixia Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of …. Hauptthemen laut MEDLINE: B7-H1 Antigen, Cell Cycle Proteins, Immunotherapy, Photochemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Taishan Scholar Project of Shandong Province, Shandong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy is an efficient approach to promote cytotoxic T lymphocyte tumor infiltration to convert immunologically cold tumors into hot tumors through the induction of immunogenic cell death . However, tumors usually overexpress immune checkpoints such as PD-L1 to suppress T lymphocyte antitumor activity and evade immune surveillance. Therefore, the design of efficient photosensitizers to overcome checkpoint-mediated immune evasion is highly necessary. In this work, we report the design of BRD-PS, a BRD4-targeting photosensitizer, as a new class of immunomodulatory photosensitizer termed an immune checkpoint-modulating photosensitizer, to solve this issue. On one hand, BRD-PS induces immunogenic pyroptosis and ferroptosis to promote the activation and tumor infiltration of cytotoxic T cells. On the other hand, BRD-PS suppresses the expression of PD-L1 to avoid immune evasion. This work demonstrated the feasibility of utilizing a single photosensitizer to simultaneously induce immunogenic cell death and PD-L1 downregulation for synergistic cancer photoimmunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenCell Cycle ProteinsImmunotherapyPhotochemotherapyPhotosensitizing AgentsTranscription FactorsAnimalsFemaleHumansMiceAntineoplastic AgentsCell Line, TumorFerroptosisImmune Checkpoint InhibitorsNeoplasmsPyroptosisT-Lymphocytes, CytotoxicHeterocyclic Compounds, 4 or More RingsBromodomain Containing Proteins

Substanzen

Antineoplastic AgentsB7-H1 AntigenCell Cycle ProteinsImmune Checkpoint InhibitorsPhotosensitizing AgentsTranscription FactorsHeterocyclic Compounds, 4 or More RingsBRD4 protein, humanBromodomain Containing ProteinsCD274 protein, human

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R.…
  • Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, P. R. China.
  • Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shenzhen Research Institute, Shandong University, Jinan, Shandong 250012, P. R. China.

ORCID-Profile: Xinke Zhang, Donghai Li, Gang Shan

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Taishan Scholar Project of Shandong Province
  • Shandong University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, P., Du, Y., Qiu, J., Jiang, Q., Chen, W., Zhang, X., Li, G., Li, D., & Shan, G. (2024). Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01362

Vancouver

Li P, Du Y, Qiu J, Jiang Q, Chen W, Zhang X, et al. Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01362

BibTeX
@article{Li2024,
  author = {Li, Peixia and Du, Yayin and Qiu, Jingru and Jiang, Qiaoyun and Chen, Weijia and Zhang, Xinke and Li, Guiling and Li, Donghai and Shan, Gang},
  title = {Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01362}
}
Kostenlos starten →